BEIRUT, Lebanon and SOFIA, Bulgaria, June 7, 2021/ PRNewswire/– DermaVita again reports favorable findings gotten in its favor versus Allergan worrying the brand JUVEDERM.
JUVEDERM box The GENERAL COURT OF THE EUROPEAN UNION in Luxembourg (CVRIA) promoted the EUIPO choice dated 31/07/2019 (see below *), for revocation and overall withdrawal of the rights for Allergan Holdings France for its European brand JUVEDERM ULTRA No 006295638 for “dermic implants, consisting of visco-supplementation compounds for medical usage, planned for wrinkle filling or volume increasing” – Class 10 items, while at the exact same time ordering Allergan Holdings France to pay the costs to DermaVita:
* On 31/07/2019, the Board of Appeal of The European Union Intellectual Property Workplace (EUIPO), following an Application for Cancellation filled by DermaVita, ruled for a total withdrawal of the rights for Allergan Holdings France for its European brand JUVEDERM ULTRA No 006295638 for Class 10 products.Furthermore, on 14/04/2021
, a Decision on an Application for Revocation, filled by DermaVita and with Recordial file No T019716672 was provided by the Cancellation Division of The European Union Intellectual Property Office (EUIPO). It sets a total revocation and removal from the register of the Allergan Holdings France’s European brand name JUVEDERM FORMA No 006547053 in Class 5– “pharmaceutical preparations for the treatment of glabellar lines, facial wrinkles, asymmetries and flaws and conditions of the human skin” and Class 10– “dermal implants, particularly, visco-supplementation options for filling wrinkles”.
DermaVita is especially decided to continue the procedure to prove the bad faith of Allergan in using the brand name JUVEDERM, as the JUVEDERM brand has actually been the subject of PRIOR USAGE because 1999 for cosmetic products and for registration in Class 5 for pharmaceutical products by DermaVita. This has been currently ruled out with judgment in favor of DermaVita against Allergan in the beginning Instance Court on 23/06/2011 and confirmed on 29/01/2015 by The Supreme Court with a final and irreversible decision.DermaVita praises
its partners and contragents for this effective outcome!Source: www.dermavita.net SOURCE DERMAVITA.NET Associated Hyperlinks http://www.dermavita.net Modal title Source